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ABSTRACT
Background Data: Identification of the prognostic factors of the surgical outcomes of intramedullary
spinal cord tumors (IMSCTs) is essential. Many studies have established that early surgical intervention
was associated with better outcomes and enhanced survival rates.
Purpose: This study investigated the prognostic factors of the one-year surgical outcomes of patients
with IMSCTs.
Study Design: A prospective clinical case study.
Patients and Methods: Twenty patients with IMSCTs, who underwent surgery in our institution and
were followed up at our clinic were recruited for this study. Patients were followed up for one year to
assess postoperative functional outcomes using the modified McCormick Scale (MMS). The reported
parameters included preoperative MMS, use of operative monitoring, use of ultrasonic aspirator, the
extent of tumor resection, and postoperative adjuvant therapy.
Results: Operatively, 85% of patients underwent laminectomy, 55% reported growth total resection
(GTR), 55% intraoperative monitoring, 75% underwent ultrasonic aspiration, 55% had syrinx, and 20%
had duraplasty. The preoperative MMS improved from 3.0 to 2.32 and 2.42 postoperatively at six months
and one year of follow-up, respectively. Patients with postoperative MMS ≤3 were more likely to undergo
GTR with better postoperative MMS than those with preoperative MMS >3 at six-month follow-up
(81.8% vs. 25%, respectively; p = 0.013) and at one-year follow-up (84.4 vs. 0%, respectively; p = 0.001).
Good preoperative MMS, use of ultrasonic aspirator, and neuromonitoring were associated with better
MMS. There were no significant associations between MMS at the sixth month and reported parameters
including gender, symptoms duration, tumor location, bony work whether laminectomy or laminoplasty,
number of segments involved, tumor histopathology, duraplasty, and postoperative adjuvant therapy.
Conclusion: The findings of the current study showed that patients with GTR, good preoperative MMS,
intraoperative monitoring, and ultrasonic aspirator usage might be associated with better functional
outcomes. (2021ESJ229)
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INTRODUCTION

PATIENTS AND METHODS

Intramedullary spinal cord tumors (IMSCTs)
account for 10% to 20% of primary SCTs, with
an incidence of 1.1 per 100,000 people.3,11 The
prevalence of IMSCTs in children is much higher
than in adults (35% vs. 20% respectively). 24
Ependymomas and astrocytomas are the most
frequent (80%) histological types of IMSCTs.26
Compared to children, ependymoma is most
common in adults and associated with various
clinical presentations based on location and
malignancy. 3 However, in elderly patients
(≥65 years), the incidence of ependymomas
and astrocytomas is comparable. 3 Children’s
astrocytomas display indolent biological activity,
which can only be explained by the histological
characteristics.1 Notwithstanding, age is one of
the most valuable prognostic factors in IMSCTs,
especially astrocytomas.6
Cushing initiated the first surgical decompression
of the IMSCTs in 1905, 10and Von Eiselberg
and Ranzi removed an IMSCT successfully in
1907. 12 Since then, developments in surgical
techniques, anesthesia, and even pharmacological
management have followed successively.21
The IMSCTs remain a major challenge for
neurosurgeons, despite recent advancements
in neurophysiological monitoring techniques,
microsurgical instr uments, and medical
equipment.21,25 These challenges are attributed
to its relatively low prevalence, uncertain natural
history, and difficulty in standardizing therapy.33
Therefore, identification of the prognostic
factors of the surgical outcomes of IMSCTs is
essential. Many studies have established that early
surgical intervention for IMSCTs was associated
with better outcomes and enhanced survival
rates.17,34 Moreover, it was suggested that tumor
histology, growth total resection, and preoperative
neurological function have a significant predictive
value in such cases.15,18,32
This case series clinical study reports the prognostic
factors of the one-year outcomes of patients with
IMSCTs undergoing surgery.

The preparation of this manuscript has been in
concordance with the STROBE guidelines.13 A
prospective clinical case study was performed on
20 patients with IMSCTs with one-year follow-up.
Patients underwent surgery at our main university
hospitals between January 2017 and May 2018.
Patients were submitted for full history taking,
general examination, neurological examination,
and routine laborator y investigations.
Preoperatively, contrast-enhanced MRI of the
index spinal segment, spinal angiography,
and MRI tractography study, if needed, were
performed. We included all radiologically proved
symptomatic fresh IMSCT with no restrictions
regarding age, sex, clinical status, race, and tumor
characteristics. We excluded patients with no
reliable data to calculate postoperative functional
outcomes, filum terminale lesions, recurrent
intramedullary tumors, and contraindications
to general anesthesia. Informed consent was
signed by all eligible patients. The study has been
approved by our IBR.
We retrieved preoperative data related to
demographic characteristics of the patients,
symptoms, tumor location, and level of tumor
extension. The preoperative functional status
was assessed using the modified McCormick
Scale (MMS).23 In this scale, patients are graded
into one of five categories according to their
functional status: grade I, normal functions; grade
II, mild sensorimotor disturbance with no need for
support; grade III, more severe disturbance with
the need for support; grade IV, severe disturbance
with essential assistance; grade V, severe deficit
requiring a wheelchair.
Operative Procedure:
Patients underwent their procedures under
general anesthesia with no muscle relaxants, in
case of electrophysiological monitoring, in the
prone position. We performed a linear, midline
skin incision, followed by muscle splitting. Then,
laminectomy or laminoplasty was performed,
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with the aid of an ultrasound probe whenever
feasible. The dura was incised in the midline
and retracted by tenting sutures. This step was
followed by a midline incision of the crossing
nerve fibers localized to the posterior median
sulcus and the tumors were exposed. The tumors
were removed by central debulking, with the aid
of the ultrasound aspirator whenever feasible
(Figures 1 and 2). Consequently, an attempt
to excise the tumor totally was made, with the
guidance of electrophysiological monitoring used
whenever feasible. After removing the tumor,
wound layers were closed tightly, and drains with
no negative suction were inserted if feasible. The
excised tumors were sent for histological typing
and grading. According to our center protocols,
the intraoperative monitoring of the patients
was done via somatosensory evoked potentials
(SSEPs) and motor evoked potentials (MEPs).
Patients were assessed during the postoperative
period for perioperative complications, MMS
functional outcomes, postoperative radiotherapy,
and chemotherapy. The postoperative MMS was
collected at six months and one year after the
operation.
Statistical Analysis:
Retrieved data were summarized and processed
with IBM SPSS statistical software (version
25). Frequencies were used to describe gender,
symptoms, tumor location, histological type,
histological grade, the extent of resection, type of
surgical repair, use of duraplasty, intraoperative
monitoring, ultrasound aspiration, postoperative
radiotherapy, postoperative chemotherapy, and
incidence of complications. On the other hand,
age, duration of the tumor, and MMS were
summarized into median (range) or mean ±
standard deviation (SD). The hypothesis
of significant associations between various
parameters and MMS was tested using chi-square
test for categorical variables and Mann–Whitney
test for continuous variables. A p value <0.05 was
regarded as statistically significant.
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RESULTS
A total of 20 patients were included, 19 patients
completed the follow-up, and one patient died
before the end of the first year. The mean age
of the patients was 36.5 ± 17.3 (range, 12–68)
and the majority were females (60%). The
mean duration of symptoms was 4 ± 2.7 (range,
0.13–10) months. Most of the patients had pain,
motor, and sensory involvements (30%) or motor
and sensory involvements only (30%). The most
common tumor location was cervical tumors
(70%), followed by dorsal tumors (30%). Overall,
40% of the patients had segmental involvement of
>4 segments. The median preoperative MMS was
3.0 ± 1.1 (range, 1–5) (Table 1).
Intraoperatively, growth total resection (GTR)
has been achieved in 55% of patients, whereas
a subtotal resection (STR) of tumors has been
achieved in 45%. Meanwhile, in 55% of the
patients, intraoperative monitoring IOM (SSEP
and MEP) was used; in 75%, an ultrasonic
aspiration was used; in 20%, a duraplasty has been
used. The mean operative time was 126.5 ± 27.6
(range, 90–190) minutes, and the mean blood loss
was 542.5 ± 196.2 (range, 200–900) ml. The mean
hospital stay was 5.2 ± 2.8 (range, 3–14) days
(Table 2).
Following surgery, 65% and 25% of the patients
underwent postoperative radiotherapy and
chemotherapy alone, respectively, while 10%
received both chemotherapy and radiotherapy.
The mean preoperative MMS (3 ± 1.1) improved
postoperatively to 2.95 ± 1.1, 2.42 ± 0.82, and
2.31 ± 0.83 at the immediate, six-month, and oneyear postoperative follow-up, respectively. Eleven
patients (55%) and 13 patients (65%) had MMS
<3 the end of the sixth month and one year of
follow-up, respectively (p < 0.005) (Figure 3).
Patients with postoperative MMS ≤3 were more
likely to undergo GTR with better postoperative
MMS than those with preoperative MMS >3 at
six-month follow-up (81.8% vs. 25%, respectively;
p = 0.013) and at one-year follow-up (84.4 vs. 0%,
37

The

EGYPTIAN SPINE
Journal
respectively; p = 0.001). The use of ultrasonic
aspiration during tumor excision was associated
with better postoperative MMS (p = 0.002), as
patients with postoperative MMS ≥3 were less
likely to undergo ultrasonic aspiration (37.5% vs.
100%, respectively. The use of IOM (SSEP and
MEP) was associated with better postoperative
MMS (p = 0.035). There were no significant
associations between MMS at the sixth month and
reported parameters, including gender, symptoms
duration, tumor location, bony work whether
laminectomy or laminoplasty, number of segments
involved, tumor histopathology, duraplasty, and
postoperative adjuvant therapy (p > 0.05) (Table
3).
Reported complications in this study showed
that seven patients developed postoperative
complications. Four patients (20%) developed

postoperative motor deterioration motor
weakness. They were grade 4-5 prior to surgery
and developed dense paraplegia postoperative
(grade 1). With follow-up, two improved to
(grade 3), while the other two did not improve.
One patient with cervicomedullary anaplastic
ependymoma developed motor weakness with
respiratory failure and subsequently died 14 days
postoperatively. Another patient developed CSF
leak that responded well to conservative treatment
in one week. Finally, one of the patients showed
rapid regrowth of a residual tumor one month
after the operation that necessitated radical
excision with recent modalities like intraoperative
monitoring and Cavitron Ultrasonic Surgical
Aspirator (CUSA). It is so important to start
adjuvant therapy rapidly for high-grade lesions.

Table 1. Summary of epidemiological data (N = 20).

Table 2. Summary of perioperative data (N = 20).

Parameters

Results

Age/years

36.5 ± 17.3

Male

8 (40%)

Females

12 (60%)

Parameters

Results

Operative time, minutes

126.5 ± 27.6

Operative blood loss, cc

542.5 ± 196.2

Gender

Symptom’s duration/months

4 ± 2.7 (range,
0.13–10)

Cervical

16 (70%)

Dorsal

6 (30%)

Ependymoma

11 (55%)

Astrocytoma

7 (35%)

Cavernoma

2 (10%)

Preoperative

3 ± 1.1

Postoperative

2.95 ± 1.1

6 months
postoperatively

2.42 ± 0.82

12 months
postoperatively

2.31 ± 0.83

Technique

Level

Pathology

MMS

38

Tumor
resection

Complications

Adjuvant
therapy

Laminectomy

17 (85%)

Laminoplasty

3 (15%)

Durolasty

4 (20%)

IOM

8 (40%)

Ultrasonic aspiration

15 (75%)

GTR

11 (55%)

STR

9 (45%)

CSF leak

1 (5%)

Deterioration

4 (20%)

Death

1 (5%)

Recurrence

1 (5%)

Chemotherapy

13 (65%)

Radiotherapy

5 (25%)

Both

2 (10%)

Hospital stay/days

5.2 ± 2.8
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Table 3. Pre-, intra-, and postoperative characteristics of the included patients.
Six months

One year

Case Report

MMS < 3 (N =
11)

MMS ≥3
(N = 8)

p value

MMS < 3
(N = 13)

MMS ≥3
(N = 6)

p value

Age/years

28 (20–68)

45.5 (12–60)

0.91

35 (20–68)

39 (16.5–60)

0.57

Females

4 (36.4%)

4 (50%)

0.55

5 (38.5%)

3 (50%)

0.63

Symptom’s duration/
months

4 (0.13–8)

5 (2–10)

0.27

4 (0.13–9)

5 (2–10)

0.36

0.38

4 (30.8%)
4 (30.8%)
3 (23.1%)
0
2 (15.4%)

2 (33.3%)
2 (33.3%)
1 (16.7%)
1 (16.7%)
0

0.43

4 (66.7%)
0
1 (16.7%)
1 (16.7%)
0

0.38

Symptoms
Pain, motor, and sensory
Pain and motor
Pain and sensory
Pain
Pain, motor, sensory,
sphincter

3 (27.3%)
4 (36.4%)
2 (18.2%)
0
2 (18.2%)

3 (37.5%)
2 (25%)
2 (25%)
1 (12.5%)
0
Location

Cervical
Cervicodorsal
Cervicomedullary
Dorsal
Dorso-lumbar

4 (36.5%)
3 (27.3%)
2 (18.2%)
1 (9.1%)
1 (9.1%)

5 (62.5%)
0
1 (12.5%)
1 (12.5%)
1 (12.5%)

0.44

5 (38.5%)
3 (23.1%)
2 (15.4%)
1 (9.1%)
2 (15.4%)

>4 segments

3 (27.3%)

4 (50%)

0.31

4 (30.8%)

3 (50%)

0.42

Laminectomy

10 (90.9%)

6 (75%)

0.35

12 (92.3%)

4 (66.7%)

0.15

Growth total resection

9 (81.8%)

2 (25%)

0.013*

11 (84.6%)

0

0.001*

Duraplasty

2 (18.2%)

2 (25%)

0.72

2 (15.4%)

2 (33.3%)

0.37

IOM

7 (63.6%)

1 (12.5%)

0.035*

8 (61.5%)

0

0.025*

CUSA

11 (100%)

3 (37.5%)

0.002*

12 (92.3%)

2 (33.3%)

0.007*

0.33

3 (23.1%)
2 (15.4%)
10 (61.5%)

3 (50%)
0
1 (16.7%)

0.11

Histological type
Astrocytoma
Cavernoma
Ependymoma

1 (9.1%)
1 (9.1%)
9 (81.8%)

5 (37.5%)
1 (12.5%)
2 (25%)
Grade

Low
High

8 (71%)
2 (18.2%)

5 (67.5%)
2 (25%)

0.68

9 (69.2%)
2 (15.4%)

4 (66.7%)
2 (33.3%)

0.48

Preoperative MMS <3

7 (63.6%)

1 (12.5%)

0.035*

9 (69.2%)

1 (16.7%)

0.032*

0
0
1 (16.7%)
3 (33.3%)

0.13

Complications
CSF leak, meningitis
Recurrence
Weakness, G2
Weakness, G3

1 (9.1%)
1 (9.1%)
0
0

0
0
1 (12.5%)
3(255)

0.17

1 (7.9%)
1 (7.9%)
0
0

Postoperative radiotherapy

8 (72.8%)

7 (87.5%)

0.43

9 (69.2%)

6 (100%)

0.92

Postoperative
chemotherapy

3 (27.3%)

4 (50%)

0.31

3 (23.1%)

4 (66.7%)

0.067
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Figure 1. A 37-year-old male
with cervical intramedullary
ependymoma. Postcontrast
enhancement (A) T1 sagittal
and (B) T1 axial images
showing C3-C7 ependymoma
with caudal T1-T2 syrinx. (C)
Postoperative T2 sagittal MRI
image showing tumor GTR with
the disappearance of the syrinx.
(D, E) Operative photos showing
steps of tumor resection with the
plane of cleavage between tumor
and spinal cord.

Figure 2. A 26-yearold female with conus
medullaris cavernoma.
Postcontrast
enhancement (A) T1
sagittal, (B) T2 sagittal,
(C) and T1 axial
MRI images showing
conus cavernoma.
Postoperative
postcontrast
enhancement (D) T1
sagittal, (E) T2 sagittal,
and T2 axial MRI
images showing tumor
GTR.
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Time point

Figure 3. The change in MMS over the study’s period.

DISCUSSION
In this prospective study, we highlighted the
prognostic factors of IMSCTs surgery in 20
Egyptian patients. Patients with IMSCTs
usually present with motor, sensory, or sphincter
disturbances.31 Preoperative assessment of the
neurological functions is a key determinant of the
surgical outcomes. Many scales were developed,
including Cooper–Epstein scale,9 Klekamp–Samii
scoring system,19 and MMS 23, in order to assess
functional outcomes. Due to its common use in the
literature and its simplicity and ease of use, many
surgeons prefer the MMS. Here, we used the MMS
to evaluate our patients pre- and postoperatively.
One-third of our patients presented with pain,
motor, and sensory affection and one-third had only
sensory and motor involvement. A significantly
higher percentage of neurological disturbance was
reported by Kane et al.17 (72%) and Chandy et al.7
(95.8% motor and 82.5% sensory involvement).
Mostly, the sensory disturbance was the first to
be mentioned in the previous studies, followed by
motor disturbance.16,36,38 In this study, the reported
median of disease duration was 4 (0.13–10)
months, which is significantly shorter than that of
Constantini et al.8 (11.6 months), Bansal et al.3 (3

Egy Spine J - Volume 37 - January 2021

years), Brotchi et al.5 (4.5 years), and Cooper et.
al.9 (9.5 years). This substantial variation can be
attributed to the histological type of malignancy
and its location. In this study, cervical tumors
were the most common type (45%), followed by
dorsal tumors (20%). Data from 29 studies showed
that most of the IMSCTs are in the cervical
region (53.0%).2 Brotchi et al.5 reported a higher
percentage of cervical tumors (55.3%) than ours,
whereas Bansal et al.3 and Kane et al.17 reported a
lower percentage, 25% and 33%, respectively.
At baseline, the median preoperative MMS of
our patients was 3 (1–5). Similarly, most of the
patients of Bansal et al.3 had an MMS of 2 and 3 at
presentation. Furthermore, the operation resulted
in mild complications, most commonly weakness.
GTR was achieved successfully in 55% of the
reported patients. Patients with MMS <3 were
more likely to achieve GTR than those with MMS
>3 (p = 0.001). IMSCT resection is usually based
on the existence or absence of a clear operative
dissection plane.4,22,29 This clear plane of cleavage
between the SC and the tumor is usually seen
in the ependymomas, unlike the astrocytomas,
which tend to be more infiltrative due to the lack
of a good dissection plane.14,39,28 In our study,
about 75% underwent ultrasound aspiration,
55% had syrinx, and 20% received duraplasty.
41
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It was reported that operations with syrinx were
associated with a higher rate of GTR than those
without syrinx (52.7% vs. 36.6%).1 In patients
with syringomyelia, Chandy et al.7 achieved a
successful radical excision in 68%. Patients with
hemangioblastoma and ependymoma are mainly
linked with syrinx.
MRI was the imaging study of choice in our
study, as it has superior soft tissue demarcation,
in addition to the capacity of multiplanar imaging
and no irradiation exposure. MI studies were also
beneficial in detecting the presence of cysts, either
intratumoral cysts (commonly seen with highgrade astrocytomas) or syringomyelia. Regarding
the relationship of imaging characteristics to
pathology, we observed that it was extremely
difficult to differentiate ependymomas and
astrocytomas on T1WI and T2WI basis. Postcontrast imaging proved that ependymomas
tended to be more homogenously and intensely
enhancing than astrocytomas; moreover, it helped
differentiate between syringomyelia and tumorrelated cyst. Klekamp and Samii19, in their study of
100 intramedullary cases, found that, in general,
the presence of an associated syrinx favored the
resectability of the tumor because it indicated
a displacing rather than an infiltrating tumor.
Patients with syringomyelia tended to recover
from surgery sooner. However, surgical results
and long-term prognosis were not influenced
significantly by an associated syrinx. In our study,
presence of syringomyelia was not statistically
significant for the outcome. The most important
factor determining long-term outcome was the
preoperative level of neurological function
According to the recent recommendations,
primary resection is the first-line treatment in
IMSCTs management (Class I), followed by
radiation and chemotherapy (Classes IIa and
IIb).35 Primary resection can be replaced with
radiation or chemotherapy in contraindicated
resection cases or the cases of astrocytoma due to
the substantially high incidence of neurological
complications postresection in this type.18
42

Almost 65% and 25% of our patients underwent
postoperative radiotherapy and chemotherapy,
respectively, and 10% underwent both. A recent
meta-analysis demonstrated that pooled data
of 29 studies revealed that resection is the most
commonly performed surgery (76.7%) in patients
with IMSCTs. Moreover, the rate of GTR was
higher than STR (39.7% vs. 37.0%), respectively.
In terms of efficacy, they showed that patients
with GTR had better survival outcomes than those
with STR.2 Another study reported that GTR
was associated with a good prognosis of surgical
outcomes (OR = 0.083, 95% CI: 0.014, 0.51).37
According to the traditional treatment method,
ependymoma patients should be treated with
radiotherapy after surgery to improve their
prognosis. However, recent studies have proved
that low-grade ependymoma patients treated with
whole surgical resection do not need radiotherapy
if there is no CSF spread. Ependymoma and
anaplastic ependymoma patients who received
whole surgical resection can experience an
improved survival rate as the short-term survival
rate and 10-year survival rates are 70% and 50%,
respectively.
Our findings showed that IMSCTs surgeries were
associated with improved overall neurological
functional status. This improvement exhibits a
significant decline in the MMS postoperatively.
In addition, lower MMS was shown to be related
to better outcomes. Richards et al.27 indicated
that MMS was improved in 16.6% of the cases
postoperatively. On the other hand, MMS
remained unchanged in 57.1% and worsened in
26.2% of the patients. Tsuji et al.37 showed that
elderly patients (OR = 1.05, p = 0.046) and severe
preoperative MMS (OR = 2.10, p = 0.007) are
related to poor results of IMSCTs management.
Low preoperative MMS score was identified as the
strongest predictor of successful GTR by Klekamp
et al.20, who analyzed 100 patients with IMSCTs
who underwent surgical treatment. Besides, they
found that old age, long disease duration, and
thoracic location were risk factors for permanent
postoperative neurological complications.
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Our review underlines that the most important
prognostic factor in determining postoperative
neurological status in the long term is the patient’s
functional status at surgery and highlights the
importance of early diagnosis and surgery. An
early diagnosis markedly influences patients’
functional prognosis and quality of life. According
to our experience in treating patients with IMSCTs,
we conclude that the determinant predictors of a
good outcome after surgery are the histological
type of lesion, complete removal of the lesion, and
a satisfactory neurological status before surgery.
This study had some limitations as follows: 1)
there is a potential selection bias as it is a singlecenter study; 2) the sample size is relatively small,
which may hinder our ability to generalize our
findings; 3) the studied surgeries were conducted
by more than one surgeon, leading to a variation
in the surgical outcomes based on the experience
and learning curve; 4) we did not compare
between the GTR and STR to show the difference
in prognostic factors; 5) the analysis was limited
to the total population without conducting
a subgroup analysis according to the tumor
histology or grade. A better balance between
tumor control and functional preservation may
be achieved not only by the surgical technique or
expertise but also by intraoperative monitoring
(SSEP, MEP), vascular image guidance, ultrasonic
aspiration, and postoperative supportive care,
including rehabilitation. Further studies with a
longer follow-up period and larger sample size
are required to evaluate the prognostic factors of
IMSCTs management.

CONCLUSION
The findings of the current study showed that
patients with GTR, good preoperative MMS,
intraoperative monitoring, and ultrasonic aspirator
usage might be associated with better functional
outcomes.
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الملخص العربي
العوامل المؤثرة في النتيجة الجراحية ألورام العمود الفقرى داخل النخاع الشوكى :دراسة متابعة مستقبلية
لمدة عام

البيانـات الخلفيـة :تحديـد العوامـل النذيـر للنتائـج الجراحيـة ألورام النخـاع الشـوكى أمـر ضـروري .أثبتـت العديـد مـن
مرتبطا بنتائج أفضل ومعدالت بقاء معززة.
ً
الدراسات أن التدخل الجراحي المبكر الورام النخاع الشوكى كان
الغـرض :حققـت هـذه الدراسـة فـي العوامـل اإلنذاريـة لنتائـج سـنة واحـدة للمرضـى الذيـن يعانـون مـن اورام النخـاع
الشوكى و يخضعون لعملية جراحية.

مصابا باورام النخاع
مريضا
ً
تصميم الدراسة :عينة المريض  ،مقاييس النتائج :تم إجراء دراسة مستقبلية على 20
ً
الشوكى  ،والذين خضعوا لعملية جراحية في مستشفيات جامعة اإلسكندرية الرئيسية .تمت متابعة المرضى لمدة
عـام واحـد لفحـص تأثيـر المعلمـات قبـل الجراحـة علـى النتائـج الوظيفيـة بعـد العمليـة الجراحيـة  ،والتـي تـم تقييمهـا
بواسطة مقياس ماكورميك المعدل(MMS).

المرضى والطرق :ال توجد قيود على عمر المريض أو جنسه أو خصائص الورم .استبعدنا المرضى الذين ليس لديهم
بيانات موثوقة لحساب النتائج الوظيفية بعد الجراحة  ،وآفات الخيط االنتهائى  ،و االورام المرتجعة.

النتائـج .كان وسـيط رسـائل الوسـائط المتعـددة قبـل الجراحـة  .)5-1( 3أثنـاء العمليـة الجراحيـة  ،خضـع  ٪85لعمليـة
استئصال الصفيحة الفقرية و  ٪55حصلوا على استئصال كلي .باإلضافة إلى ذلك  ،خضع  ٪55من المرضى للمراقبة
أثناء العملية  ،وخضع  ٪75من المرضى للشفط بالموجات فوق الصوتية  .تغير الوسيط  MMSبشكل ملحوظ ليصل
مريضا ()٪65
ً
مريضا ( )٪55و 13
ً
إلى  )4-1( 2في نهاية الشـهر السـادس وسـنة واحدة من المتابعة .كان لدى 11
رسـائل  MMSأقـل مـن  3فـي نهايـة الشـهر السـادس وسـنة واحـدة مـن المتابعـة  ،علـى التوالـي ( P <0.005).كان
المرضى الذين يعانون من  MMS ≥3أكثر عرضة للخضوع لالستئصال الجزئي من المرضى الذين يعانون من MSS <3
في نهاية الشـهر السـادس وسـنة واحدة من المتابعة ( p = 0.013و =  ، 0.002على التوالي) .لم يكن هناك ارتباط
معنـوي بيـن  MSSفـي الشـهر السـادس والمتغيـرات المدروسـة األخـرى .أظهـر تحليـل االنحـدار أن أيـا مـن المتغيـرات
المشتركة المدروسة لم تكن تنبؤات مستقلة للشهر السادس والرسائل المتعددة الوسائط لمدة عام.
الخالصـة :فـي الختـام  ،أظهـرت نتائـج الدراسـة الحاليـة أن المرضـى الذيـن يعانـون مـن االسـتئصال الكامـل مـع حالـة
سـريرية جيـدة قبـل الجراحـة والشـفط بالموجـات فـوق الصوتيـة قـد يرتبطـون بنتائـج وظيفيـة أفضـل .لـم نتمكـن مـن
تحديد أي تنبؤات مستقلة لرسائل الوسائط المتعددة قصيرة أو طويلة المدى.
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